Raising Health

Suchi Saria, AI trailblazer, discusses her vision to create 'clinical copilots' that augment human capabilities and unburden care teams. She emphasizes the delicate balancing act required to implement AI ethically and offers a lifeline for founders navigating uncertain regulatory seas. Saria's insights map guideposts for founders aspiring to positively disrupt healthcare with AI.

Fei-Fei Li, professor at Stanford University and co-director of Stanford's Human-Centered AI Institute, shares her journey and discusses the birth of ImageNet. They also explore the concept of a 'Dignity Economy' and touch on the balance between innovation and life's pursuits. A glimpse into the personal and professional realms of an AI pioneer shaping the landscape.

Evan Feinberg, founder and CEO at Genesis Therapeutics, talks about using AI in drug discovery and the collaboration between ML, biotech, and chemistry. They discuss how physics-based models can improve drug design, integrating human intuition and predictive AI models, and the importance of a multidisciplinary team in drug discovery programs.

Olga Troyanskaya, a professor in the department of computer science at Princeton, discusses the impact of evolving biotechnologies on genomics. They explore the intersection of computer science and biology, advancements in genomics tools and technologies, integration of genomics with environment and health, and the importance of making biotechnological tools accessible.

Peter Shalek, Chief Product Officer at Stellar Health, and Reena Pande, strategic advisor, discuss improving CMO/CPO relations in healthcare startups. They offer practical advice, share real-life examples, and emphasize the importance of collaboration and alignment between clinical and product teams. They also talk about defining and balancing products in tech-enabled services companies and the effective working dynamics between CMOs and CPOs.

Surya Ganguli, a neural dynamics researcher at Stanford University, joins Vijay Pande to discuss interpretability in AI, and the potential for AI to become a 'clear box'. They explore the future of AI-augmented humans and the importance of understanding AI systems. They also touch on the cost of training AI models, meta learning, regulatory frameworks, and the need for interdisciplinary collaboration.

Daphne Koller, founder and CEO at insitro and AI expert, discusses the use of AI in life sciences, including the POSH approach for potential therapeutic interventions. They also explore the power of AI in analyzing cellular images and clinical data, and the challenges of merging biology and ML AI.

Today's episode features Aviv Regev, PhD, the Head and Executive VP of Genentech Research and Early Development, and founding co-chair of the Human Cell Atlas. She is joined by Vijay Pande of Bio + Health.Together, Aviv and Vijay talk about how Aviv's love of both abstractions and details led her to biology, how CRISPR really set the field into motion, and how AI could transform the process of biological and medical discovery.

Andrew Ng, a distinguished authority in the field of AI, discusses integrating AI into different areas of our lives and the concerns of AI becoming a dominant species. They explore early work in AI, multimodal language models, and the intersection of AI and startups. They also discuss the progress and limitations in AI vision, job displacement caused by AI, and potential solutions for navigating the impact of automation on jobs.

Dr. Carl June discusses his pioneering work in CAR T therapy, his journey into T cell immunology, the challenges in treating solid tumors, and the potential solutions in cancer treatment.